b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">\n        <PMID Version="1">29713841</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>09</Month>\n            <Day>24</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>05</Month>\n            <Day>21</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1435-604X</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>33</Volume>\n                    <Issue>7</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Sep</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Lasers in medical science</Title>\n                <ISOAbbreviation>Lasers Med Sci</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Comparative study using fractional carbon dioxide laser versus glycolic acid peel in treatment of pseudo-acanthosis nigricans.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>1485-1491</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10103-018-2505-x</ELocationID>\n            <Abstract>\n                <AbstractText>Pseudo-acanthosis nigricans is a common dermatological disorder that is usually difficult to treat secondary to maceration of the skin from excessive sweating, obesity, or associated with endocrine disorders. Fractional photothermolysis and chemical peeling have been reported to improve the condition. To determine whether fractional CO<sub>2</sub> laser resurfacing or glycolic acid peel is more effective and safe option for therapy. Twenty Egyptian patients were included in the study where each patient was subjected to three sessions of both fractional CO<sub>2</sub> on the right side of the neck and glycolic acid peel 70% on the left side of the neck. All patients were evaluated by a scoring system Acanthosis Nigricans Area and Severity Index (ANASI) score and three blinded dermatologists before and after treatment. Clinical improvement on the side treated by glycolic acid peel showed 43% improvement while the side treated by fractional CO<sub>2</sub> showed 19% improvement. Glycolic acid peel shows superior results to fractional CO<sub>2</sub> due to accelerated induced exfoliation, yet still fractional CO<sub>2</sub> results are promising due to a presumably long-term improvement of skin texture.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Zaki</LastName>\n                    <ForeName>N S</ForeName>\n                    <Initials>NS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, Kasr Al Ainy Teaching Hospital, Cairo University, Al-Saray Street, El Manial, Cairo, 11956, Egypt.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hilal</LastName>\n                    <ForeName>R F</ForeName>\n                    <Initials>RF</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, Kasr Al Ainy Teaching Hospital, Cairo University, Al-Saray Street, El Manial, Cairo, 11956, Egypt. rana.hilal@kasralainy.edu.eg.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Essam</LastName>\n                    <ForeName>R M</ForeName>\n                    <Initials>RM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Student Hospital, Cairo, Egypt.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D003160">Comparative Study</PublicationType>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>04</Month>\n                <Day>30</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Lasers Med Sci</MedlineTA>\n            <NlmUniqueID>8611515</NlmUniqueID>\n            <ISSNLinking>0268-8921</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D006016">Glycolates</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0WT12SX38S</RegistryNumber>\n                <NameOfSubstance UI="C031149">glycolic acid</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <CommentsCorrectionsList>\n            <CommentsCorrections RefType="ErratumIn">\n                <RefSource>Lasers Med Sci. 2018 Jul 28;:</RefSource>\n                <PMID Version="1">30054856</PMID>\n            </CommentsCorrections>\n            <CommentsCorrections RefType="ErratumIn">\n                <RefSource>Lasers Med Sci. 2019 Jan 24;:</RefSource>\n                <PMID Version="1">30680537</PMID>\n            </CommentsCorrections>\n        </CommentsCorrectionsList>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000052" MajorTopicYN="N">Acanthosis Nigricans</DescriptorName>\n                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002615" MajorTopicYN="Y">Chemexfoliation</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006016" MajorTopicYN="N">Glycolates</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D054020" MajorTopicYN="N">Lasers, Gas</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015588" MajorTopicYN="N">Observer Variation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n                <QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Acanthosis nigricans scoring system</Keyword>\n            <Keyword MajorTopicYN="N">Fractional CO2 laser</Keyword>\n            <Keyword MajorTopicYN="N">Glycolic acid peel</Keyword>\n            <Keyword MajorTopicYN="N">Pseudo-acanthosis nigricans</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>07</Month>\n                <Day>21</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>04</Month>\n                <Day>05</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>5</Month>\n                <Day>2</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>9</Month>\n                <Day>25</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>5</Month>\n                <Day>2</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29713841</ArticleId>\n            <ArticleId IdType="doi">10.1007/s10103-018-2505-x</ArticleId>\n            <ArticleId IdType="pii">10.1007/s10103-018-2505-x</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Indian Dermatol Online J. 2014 Jul;5(3):239-49</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25165638</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMJ Case Rep. 2016 Jul 25;2016:</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27457822</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Dermatol. 1976 Oct;15(8):592-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">971978</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Facial Plast Surg. 2009 Dec;25(5):329-36</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20024875</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Dermatol. 2015 Jul-Aug;33(4):466-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26051063</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lasers Med Sci. 2010 Jan;25(1):137-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19787413</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetes Care. 1999 Oct;22(10):1655-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10526730</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Eur Acad Dermatol Venereol. 2016 Mar;30(3):442-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26818779</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>An Bras Dermatol. 2012 Jan-Feb;87(1):97-104</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22481657</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cosmet Investig Dermatol. 2013 Nov 11;6:281-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24399880</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Clin Dermatol. 2014 Aug;15(4):357-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24858737</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Dermatolog Treat. 2014 Jun;25(3):223-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22494198</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'